PROCTER & GAMBLE CO (PG): what the price assumes

In the published model solve dated 2026-Q2, anchored at $143.75, PROCTER & GAMBLE CO (PG) is priced for -0.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/PG

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 7.2% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.4%); the inversion above states its own rate.

Per-Model Detail (n=16)

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Bullet Takeaways

• Procter & Gamble is a portfolio of daily-use brands across five categories, Fabric and Home Care the largest at about 35%, then Baby, Feminine and Family Care, Beauty, Health Care, and Grooming, each built on products consumers buy on routine rather than impulse.
• The franchise earns exceptional returns, a return on equity around 30% and roughly $15 billion of annual free cash flow on revenue near $87 billion, funding a dividend the company has now raised for 70 straight years.
• The defining tension is the price: every valuation method lands below where the stock trades, so the bet is that a roughly 1% organic-growth staple keeps earning a premium multiple, against a tariff and commodity headwind of about $0.25 per share for fiscal 2026.

Bull Case

The moat at Procter & Gamble is the most studied one in consumer products, and it is real precisely because it is boring. The company sells things people use up and rebuy without thinking, Tide and Pampers and Gillette and Crest, and it has spent decades making those brands the default choice on the shelf. Scale is the mechanism. P&G's roughly $87 billion of revenue gives it the largest advertising budget, the deepest retailer relationships, and the most research-and-development spend in its categories, which lets it keep its products marginally better and marginally better marketed than the alternatives, year after year. A product that is slightly superior and bought on habit is the closest thing to a recurring revenue stream that a non-subscription business can have.

The financial signature of that moat is hard to argue with. P&G earns a return on equity around 30%, generates about $15 billion in free cash flow annually, and converts its sales into operating margins above 23%. Those are returns that only a genuine competitive advantage sustains, because high returns invite competition, and competition normally erodes them. The fact that P&G has held them for decades is the evidence the moat holds. The balance sheet is a fortress: net debt sits around two times operating income, interest coverage runs above 23 times, and the company has raised its dividend for 70 consecutive years, recently lifting it another 3%. That dividend streak is not a marketing fact; it is the visible output of a business that produces more cash than it needs every single year.

Management is also pulling the levers a mature compounder should. P&G is executing a restructuring that targets up to 7,000 non-manufacturing job reductions, sharpening the cost base, and it has navigated the tariff environment better than feared, cutting its projected fiscal 2026 tariff cost roughly in half from its earlier outlook. Organic sales growth reaccelerated to about 3% in the fiscal third quarter after a flat second quarter. For an investor who wants a business that compounds slowly, returns capital reliably, and survives any economic environment, the bull case is quality, durability, and a 70-year track record of doing exactly that.

Bear Case

The bear case is not about the business, which is excellent; it is about the price, which assumes the excellence comes with growth it does not have. Every family of valuation method lands below where the stock trades. The peer-multiple methods, the earnings-power methods, the asset-based methods, and even the forward-growth methods all sit beneath the price, which means there is no standard lens that frames P&G as anything but richly valued. The reason is the mismatch between the multiple and the growth. P&G trades at roughly a 22x earnings multiple, the kind of premium a market pays for a grower, while its organic sales growth runs in the low single digits, around 1% to 3%, and the inversion shows the price embedding only about 1% operating-income growth as it is. Pay a growth multiple for a no-growth-to-low-growth business and the return comes almost entirely from the dividend and buyback, not from the business expanding.

The category pressures are slow but persistent, and they cap the growth that would justify the premium. P&G's products are mature, penetrated, and increasingly contested by private-label brands that have closed the quality gap in many categories, especially when consumers trade down in a stretched economy. The company grows mostly by raising prices and nudging volumes, and there is a ceiling on how far price can run before shoppers switch to the store brand. The reaccelerating organic sales are encouraging, but mid-single-digit organic growth is the ceiling for a business this large and this penetrated, not a launchpad. The tariff and commodity headwinds, about $0.25 per share for fiscal 2026, are a reminder that input costs press directly on margins in a business with limited ability to pass them through indefinitely.

The valuation leaves little room for any of that to bite. When a stock trades above every method's central estimate, the multiple is the entire cushion, and multiples compress when growth disappoints or when interest rates make a 2%-yielding staple less attractive against bonds. The fortress balance sheet bounds the downside in the sense that P&G is in no financial danger whatsoever, but a strong balance sheet does not protect against paying too much. The bear case is the calibrated one: this is a wonderful company, and at this price the market is asking you to pay a premium multiple for low-single-digit growth, which works only if the premium holds. If the multiple reverts toward where the methods land, the dividend does not save the total return.

Valuation

P&G is a multi-segment consumer staples company, and the right comparison is to its consumer-products peers rather than to the broad market. The price is making a modest bet in growth terms, the inversion embeds only about 1% operating-income growth, but a demanding bet in multiple terms, because it pays a premium price for that low growth. The company earns a 23% operating margin today, well above what the price strictly requires of the economics, which is why the bet is really about the multiple persisting, not about a margin or growth leap.

The methods agree on direction in a way that is itself the signal: every family reads the stock as expensive. The forward-growth methods, which credit the steady low-single-digit cash-flow growth, get closest, landing modestly below the price. The peer-multiple lens, at roughly a 22x sector earnings multiple, also sits a bit below. The static earnings-power and asset methods land furthest below, because capitalizing the current cash flow with no growth, or anchoring on book value, cannot reach a price that embeds a premium for quality and durability. That pattern, no family reaching the price, is the signature of a stock priced for its franchise quality rather than its measurable cash flows. The premium is the market paying for certainty: the 70-year dividend record, the fortress balance sheet, the survives-anything category mix. Whether that premium is warranted is the question the price poses, not one the methods answer.

Solvency is a non-issue and a genuine strength. Net debt around two times operating income, interest coverage above 23 times, and roughly $15 billion of annual free cash flow mean the dividend and buyback are covered many times over, and the share count drifts down about 1% a year. For a staple, the balance sheet frame is capital-return capacity, and P&G's is among the strongest in the market. What the buyer is underwriting is not financial risk but valuation risk: paying a premium multiple for a business whose growth is low and whose moat, while durable, does not accelerate. The downside is bounded by the quality of the franchise; the return is bounded by the multiple staying where it is.

Catalysts

P&G's fiscal 2026 has shown organic sales reaccelerating through the year. Fiscal second-quarter net sales rose about 1% with organic sales roughly flat, then fiscal third-quarter net sales grew about 7% with organic sales up about 3%. Management maintained full-year guidance of all-in sales growth of 1% to 5%, organic sales growth of in-line to up 4%, and core EPS growth of in-line to up 4%, with core EPS guided to roughly $6.83 to $7.09. The next quarterly prints are the read on whether the organic growth reacceleration sustains or fades back toward flat.

The developments shaping the margin story are the restructuring and the cost headwinds. P&G is executing a plan targeting up to 7,000 non-manufacturing job reductions to streamline its cost base, and it cut its projected fiscal 2026 tariff cost roughly in half from an earlier estimate, now around $400 million after-tax, alongside about $150 million in commodity headwinds, together about $0.25 per share. The company also raised its dividend about 3%, extending a 70-year streak of annual increases. The catalysts to watch are the pace of the restructuring savings reaching the margin line, whether organic growth holds in the upper part of its guided range, and any further change in the tariff outlook, since input and trade costs press directly on a business with limited pricing headroom.

Peer Cohorts (Per Segment, With Filing Citations)

Beauty (reported)

• EL (Estee Lauder Companies Inc)
• FY2025 10-K: …candles and soaps that are based on a particular fragrance. Hair Care - Our hair care products include shampoos, conditioners, styling products, treatment, finishing sprays and hair color products. Other - The other category includes royalty revenue from our licensing of the TOM FORD trademark to third parties since…
• FY2025 10-K: …net sales associated with the fiscal 2024 third quarter launch in Amazon's U.S. Premium Beauty store, as well as the success of hero product franchises, including new product launches. 37 Table of Contents Makeup net sales were impacted by approximately $20 million of unfavorable foreign currency translation.…
• COTY (COTY INC.)
• FY2025 10-K: …A Common Stock. Risk Factors Risks related to our Business and Industry The beauty industry is highly competitive, and if we are unable to compete effectively, our business, prospects, financial condition and results of operations could suffer. The beauty industry is highly competitive and can change rapidly due to…
• FY2025 10-K: …agile innovation, social media advocacy, and expansion into body mists and masstige fragrances. Skincare remains a strategic focus, but achieving scale takes time, and we will pursue this while remaining very mindful of the investment demand. We also continue to advance key sustainability priorities. Strategic…
• KVUE (Kenvue Inc.)
• FY2025 10-K: …realization of benefits associated with our supply chain optimization initiatives, and savings from Our Vue Forward resulting in administrative expense reductions. Skin Health and Beauty Segment Skin Health and Beauty Segment Net Sales The Skin Health and Beauty Segment Net sales were $4.1 billion and $4.2 billion…
• FY2025 10-K: …revenue with $15.1 billion in Net sales in the fiscal year 2025. By combining the power of science with meaningful consumer insights and our digital strategy, we empower consumers to live healthier lives every day. Built on more than a century of heritage and trusted by generations, our differentiated portfolio of…
• CL (COLGATE-PALMOLIVE COMPANY)
• FY2025 10-K: Comparability In the fourth quarter of 2025, we recorded a non-cash charge of $794 aftertax ($919 pretax) to adjust the carrying values of goodwill and intangible assets related to the skin health business. Given lower than expected category growth rates and weaker than expected performance, particularly in China, we…
• FY2025 10-K: …reporting unit; (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management's significant assumptions related to the sales growth rates, operating margins, and discount rates; and (iii) the audit effort involved the use of professionals with specialized skill…
• UL (UNILEVER PLC)
• FY2025 20-F: …positive price offsetting volume declines. Dove delivered double-digit growth driven by the successful launch of its renovated hair care range. Meanwhile, Sunsilk and Clear were impacted by softness in several emerging markets and deliberate tail brand portfolio rationalisation. Core Skin Care grew mid-single digit,…
• FY2025 20-F: …for example through Hindustan Unilever's acquisition of the premium, actives-led beauty brand Minimalist. INNOVATION-LED PREMIUMISATION Innovation grounded in scientific expertise continues to shape our portfolio. We are focusing on scalable, multi-year innovations and leveraging leading-edge bioscience. This…
• IPAR (INTERPARFUMS, INC.)
• FY2025 10-K: …in current distribution include: First and Collection Extraordinaire. Sales of the Collection Extraordinaire line have experienced continued growth since its debut. We continue to introduce new additions to the Van Cleef & Arpels Collection Extraordinaire assortment annually, including Oud Blanc , Rêve de Matiere,…
• FY2025 10-K: …that was artistic, disruptive and a reflection of concepts explored in the realm of youth culture. Off-White blends the worlds of streetwear and luxury in a spirit of talent and inventiveness. This is a tremendous opportunity for us considering the brand's unique positioning, not to mention Virgil Abloh's impressive…
• ELF (e.l.f. Beauty, Inc.)
• FY2025 10-K: …the only risks that we face. Additional risks and uncertainties not precisely known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition, results of operations, and future growth prospects. PART I Item 1. Business. Overview e.l.f. Beauty, Inc.…
• FY2025 10-K: …to Every Eye, Lip and Face Delivering premium quality products at extraordinary prices is at the heart of our value proposition, democratizing access for millions of consumers who otherwise couldn't have the best of beauty. We believe that equally important is what goes into our products (and what doesn't) and how…
• OLPX (OLAPLEX HOLDINGS, INC.)
• FY2025 10-K: …new product introductions or promotional and planning activities undertaken by us or our customers, which may impact the timing of purchases or order placement. Competition There is significant competition within each market where our products are sold. Competition in the beauty industry is based on a variety of…
• FY2025 10-K: …protecting our premium positioning. We will continue to execute our three-tiered international strategy, prioritizing high-potential regions and improving local execution as we seek to scale our global reach in a disciplined, repeatable way. Finally, we aim to optimize our points of access to meet our consumers where…

Grooming (reported)

• EL (Estee Lauder Companies Inc)
• FY2025 10-K: …candles and soaps that are based on a particular fragrance. Hair Care - Our hair care products include shampoos, conditioners, styling products, treatment, finishing sprays and hair color products. Other - The other category includes royalty revenue from our licensing of the TOM FORD trademark to third parties since…
• FY2025 10-K: …segmented on a basis that facilitates comparison to industry statistics. Although the Company operates in one business segment, beauty products, the CEO evaluates performance based on its four major product categories: skin care, makeup, fragrance and hair care. These product categories meet the definition of…
• CL (COLGATE-PALMOLIVE COMPANY)
• FY2025 10-K: …dishwashing liquids, Ajax, Fabuloso and Murphy household cleaners and Suavitel, Soupline, Fluffy and Cuddly fabric conditioners. Sales of Oral, Personal and Home Care products accounted for 44%, 17% and 16%, respectively, of our total worldwide Net sales in 2025. Geographically, Oral Care is a substantial part of our…
• FY2025 10-K: …us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-12-31 0000021665 cl:HomeCareMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-12-31 0000021665 cl:HomeCareMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember…
• KVUE (Kenvue Inc.)
• FY2025 10-K: …us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember kvue:SkinHealthAndBeautyMember 2024-12-30 2025-12-28 0001944048 kvue:FaceAndBodyCareMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember kvue:SkinHealthAndBeautyMember 2024-01-01 2024-12-29 0001944048…
• FY2025 10-K: …in brand management and marketing, research and development and innovation, insights and analytics, and omnichannel commerce. The reportable business segments are as follows: • Self Care. Our Self Care product categories include: Cough, Cold, and Allergy; Pain Care; and Other Self Care (Digestive Health, Smoking…
• UL (UNILEVER PLC)
• FY2025 20-F: …90% of turnover. Deodorants grew low single-digit, with positive volume and price, led by strong growth in Dove. The continued success of whole-body deodorants fuelled growth, offset by a volume decline in Latin America amid softer market conditions. Across our other categories, Skin Cleansing grew mid-single digit,…
• FY2025 20-F: …strengthened its US presence with a retail expansion into Ulta Beauty, the country's largest beauty retailer, and entered its first multi-year partnership with Major League Baseball (MLB) as its Official Hair Growth Partner. The brand, which was acquired in 2022, continues to serve as a blueprint for category growth.…
• COTY (COTY INC.)
• FY2025 10-K: …we have explored and undertaken opportunities to acquire other companies and assets as part of our growth strategy. For example, we completed five significant acquisitions in fiscal 2016 through fiscal 2018 (including the acquisition of the P&G Beauty Business in October 2016), and we entered into a joint venture…
• FY2025 10-K: …efforts, including in connection with new products in our skincare and prestige cosmetics portfolios ; • changes in the demand for our products due to declining or depressed global or regional economic conditions, and declines in consumer confidence or spending, whether related to the economy (such as austerity…
• HLN (Haleon plc)
• FY2025 20-F: …programmes with major retailers focused on self-care. - Sector and customer collaboration supporting local communities. - Regular workshops to share best practices and exchange insights and strategies. - Interactive visits to our shopper research centres. - Activated UK retailer programmes for Voltarol and Centrum on…
• FY2025 20-F: …Growth Officer role to lead our growth and innovation agenda alongside the creation of six new Operating Units, which all sit on the Haleon Executive Team, bringing the voice of consumers deeper into strategic decision making. Strengthening our leadership In May 2025, we welcomed Nathalie Gerschtein as our new…

Health Care (reported)

• HLN (Haleon plc)
• FY2025 20-F: …are still influencing purchasing decisions1 . Demand is also increasing for holistic health solutions1 , digital tools, ingredient transparency, efficacy and credibility. Grocery, drug and traditional pharmacy channels are under significant pressure, with increasing input costs. Meanwhile, shifts to ecommerce and…
• FY2025 20-F: …long-term trends Access to funding for investment through equity and debt Supply chain and business continuity; support with our environmental ambitions Customers pharmacies, drugstores, retailers and ecommerce platforms Employees Governments and industry regulators Health professionals Investors Suppliers…
• KVUE (Kenvue Inc.)
• FY2025 10-K: Care (Digestive Health, Smoking Cessation, Eye Care, and Other) Skin Health and Beauty Face and Body Care Hair, Sun, and Other Essential Health Oral Care Baby Care Other Essential Health (Women's Health, Wound Care, and Other) The Company's product categories as a percentage of Net sales for the fiscal twelve months…
• FY2025 10-K: …revenue with $15.1 billion in Net sales in the fiscal year 2025. By combining the power of science with meaningful consumer insights and our digital strategy, we empower consumers to live healthier lives every day. Built on more than a century of heritage and trusted by generations, our differentiated portfolio of…
• CL (COLGATE-PALMOLIVE COMPANY)
• FY2025 10-K: …dishwashing liquids, Ajax, Fabuloso and Murphy household cleaners and Suavitel, Soupline, Fluffy and Cuddly fabric conditioners. Sales of Oral, Personal and Home Care products accounted for 44%, 17% and 16%, respectively, of our total worldwide Net sales in 2025. Geographically, Oral Care is a substantial part of our…
• FY2025 10-K: Comparability In the fourth quarter of 2025, we recorded a non-cash charge of $794 aftertax ($919 pretax) to adjust the carrying values of goodwill and intangible assets related to the skin health business. Given lower than expected category growth rates and weaker than expected performance, particularly in China, we…
• PRGO (Perrigo Company plc)
• FY2025 10-K: …primarily in Europe and Australia. During the first quarter of 2026, we have begun transitioning from a geographic segment reporting structure to a category-based segment view, enabling us to better align our financial disclosures and operational analysis with our product offerings and strategic priorities. The…
• FY2025 10-K: …including the Physiomer ® brand; • Pain & Sleep-Aids: Net sales of $235.4 million increased 6.0%, inclusive of a 4.0% favorable effect of currency translation, due primarily to restored supply of the Solpadeine ® brand; • Healthy Lifestyle: Net sales of $231.5 million increased 2.5%, inclusive of a 0.6% favorable…
• PBH (PRESTIGE CONSUMER HEALTHCARE INC.)
• FY2025 10-K: OTC healthcare products in the following product groups: Analgesics, Cough & Cold, Women's Health, Gastrointestinal, Eye & Ear Care, Dermatologicals and Oral Care. Our products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance…
• FY2025 10-K: Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.* 97.1 Prestige Consumer Healthcare Inc. Clawback Policy, dated October 2, 2023 ( filed as Exhibit 97.1 to the Company's Annual Report on Form 10-K filed on May 15, 2024 ). + 101.INS Inline XBRL Instance Document -…
• CHD (CHURCH & DWIGHT CO., INC.)
• FY2025 10-K: …supplies and services from its vendors at market prices to enable the Company to respond quickly to changes in customer orders or requirements, as well as costs associated with licensing and promotion agreements. c. As of December 31, 2025, the Company had various guarantees and letters of credit totaling $ 9.1 . d.…
• FY2025 10-K: …pass more stringent regulations in these areas, or more aggressively enforce existing regulations. As of January 1, 2026, comprehensive privacy laws are in effect in 20 states, complicating our privacy compliance obligations through the introduction of increasingly disparate requirements across the various U.S.…

Fabric & Home Care (reported)

• CLX (CLOROX CO /DE/)
• FY2025 10-K: …the United States. Products within this segment include bags and wraps under the Glad brand; cat litter primarily under the Fresh Step and Scoop Away brands; and grilling products under the Kingsford brand. • Lifestyle consists of food, water-filtration and natural personal care products marketed and sold in the…
• FY2025 10-K: …Despite these headwinds, in fiscal year 2025 the Company delivered organic sales and earnings growth while advancing its goals to build a stronger, more resilient company. While net sales were 1 Table of Contents essentially flat in fiscal year 2025, the Company grew overall market share while also expanding gross…
• CHD (CHURCH & DWIGHT CO., INC.)
• FY2025 10-K: …us to devote greater focus to our portfolio's faster growing value and premium product lines. Consumer Domestic Our founders first marketed sodium bicarbonate, otherwise known as baking soda, in 1846 for use in home baking. Today, this product has a wide variety of uses in the home, including as a refrigerator and…
• FY2025 10-K: …in a reportable segment. Commercial & Professional We also provide a line of cleaning and deodorizing products for use in commercial and industrial applications such as office buildings, hotels, restaurants and other facilities. 6 COMPETITION We compete in the household and personal care consumer product categories,…
• CL (COLGATE-PALMOLIVE COMPANY)
• FY2025 10-K: …dishwashing liquids, Ajax, Fabuloso and Murphy household cleaners and Suavitel, Soupline, Fluffy and Cuddly fabric conditioners. Sales of Oral, Personal and Home Care products accounted for 44%, 17% and 16%, respectively, of our total worldwide Net sales in 2025. Geographically, Oral Care is a substantial part of our…
• FY2025 10-K: …for Oral, Personal and Home Care were $ 3,640 in 2024. (2) Net sales in the United States for Pet Nutrition were $ 3,059 in 2024. (3) Refer to Note 17, Supplemental Income Statement for information related to Other (income) expense, net. 114 COLGATE-PALMOLIVE COMPANY Notes to Consolidated Financial Statements…
• UL (UNILEVER PLC)
• FY2025 20-F: …and South Africa. Home & Hygiene grew mid-single digit, led by Domestos and Cif, supported by premium innovations such as Infinite Clean. Fabric Enhancers grew high single-digit, led by volume, with Comfort benefiting from premium formats and fragrance-led innovations such as boosters. Operating profit decreased by…
• FY2025 20-F: …this, we are embedding AI-powered design capabilities into brand teams via Sketch Pro - our in-house studio that speeds up asset production and enables storytelling designed for social platforms. We continue to deliver executional excellence offline. We have stepped up partnerships with our customers to drive growth…
• ECL (ECOLAB INC.)
• FY2025 10-K: …high quality outcomes to commercial segments in the geographies it serves. As we expand the use of smart, connected devices, we believe our Pest Intelligence model will further contribute to our high-quality outcomes. ​ Global Life Sciences ​ This reportable segment consists of the Life Sciences operating segment. ​…
• FY2025 10-K: …for our customers including water savings, energy savings and operating efficiency. In addition, Institutional markets a lease program comprised of energy-efficient dishwashing machines, detergents, rinse additives and sanitizers, including full machine maintenance. ​ Institutional sells its products and programs…

Baby, Feminine & Family Care (reported)

• KMB (KIMBERLY-CLARK CORPORATION)
• FY2025 10-K: Baby and Child Care and Family Care categories. Increased purchases of private label products could reduce net sales of our higher-margin products which would negatively impact our profitability. While the global marketplace in which we operate has always been highly competitive, we continue to experience increased…
• FY2025 10-K: …innovation, category development and commercial execution; • leverage our cost and financial discipline to fund durable growth and improve margins; and • allocate capital in value-creating ways. To achieve these objectives, we will continue executing our Powering Care strategy and its three synergistic, strategic…
• KVUE (Kenvue Inc.)
• FY2025 10-K: Care (Digestive Health, Smoking Cessation, Eye Care, and Other) Skin Health and Beauty Face and Body Care Hair, Sun, and Other Essential Health Oral Care Baby Care Other Essential Health (Women's Health, Wound Care, and Other) The Company's product categories as a percentage of Net sales for the fiscal twelve months…
• FY2025 10-K: …value realization. Self Care Segment Self Care Segment Net Sales The Self Care Segment Net sales were $6.4 billion and $6.5 billion for the fiscal twelve months ended December 28, 2025 and December 29, 2024, respectively, a decrease of $149 million, or 2.3%. Excluding the impact of favorable changes in foreign…
• CL (COLGATE-PALMOLIVE COMPANY)
• FY2025 10-K: …dishwashing liquids, Ajax, Fabuloso and Murphy household cleaners and Suavitel, Soupline, Fluffy and Cuddly fabric conditioners. Sales of Oral, Personal and Home Care products accounted for 44%, 17% and 16%, respectively, of our total worldwide Net sales in 2025. Geographically, Oral Care is a substantial part of our…
• FY2025 10-K: …us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-12-31 0000021665 cl:HomeCareMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-12-31 0000021665 cl:HomeCareMember us-gaap:ProductConcentrationRiskMember us-gaap:SalesRevenueNetMember…
• UL (UNILEVER PLC)
• FY2025 20-F: …and confidence in whole-body self-care. Strategic Report Unilever Annual Report on Form 20-F 2025 21 REVIEW OF THE YEAR Premiumising Personal Care We drove strong growth in hard currency, delivered through our Power Brand premiumisation and category-disrupting innovation. Fabian Garcia Business Group President,…
• FY2025 20-F: …good performance, with many achieving double-digit growth, supported by science-led, premium innovation and social-first marketing. Leandro Barreto Chief Marketing Officer - Unilever and Beauty & Wellbeing ABOUT BEAUTY & WELLBEING Our categories: Hair Care, Prestige Beauty, Skin Care and Wellbeing Our Power Brands:…
• EL (Estee Lauder Companies Inc)
• FY2025 10-K: …candles and soaps that are based on a particular fragrance. Hair Care - Our hair care products include shampoos, conditioners, styling products, treatment, finishing sprays and hair color products. Other - The other category includes royalty revenue from our licensing of the TOM FORD trademark to third parties since…
• FY2025 10-K: …as of May 31, 2022 (filed as Exhibit 10.1 on our Quarterly Report on Form 10-Q filed on May 3, 2022) (SEC File No. 1-14064).*† 10.3b The Estee Lauder Companies Retirement Growth Account Plan, as amended and restated, effective as of January 1, 2023 (filed as Exhibit 10.1 to our Quarterly Report on Form 10-Q filed on…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.